Atlas Trials

A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

Clinical trial NCT05254366 · COMPLETED

Trial details

NCT number
NCT05254366
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Gastroscopic and Colonoscopic Sedation
Start date
2022-01-30
Primary completion
2023-02-08
Enrollment
2022

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.